glp 1 diabetes Researchers find GLP-1 medications safe to continue before surgery in patients with and obesity Schematic of action of GLP-1

They act partly by imitating a gut hormone involved in appetite regulation, insulin secretion and blood glucose control

doi: 10.1056/NEJMoa1603827 38 PfefferMAClaggettBDiazRDicksteinKGersteinHCKberLVet al

Rather than functioning as a patient support environment, the platform operates as a cultural commentary arena

Zepbound and Mounjaro contain the same active ingredient (tirzepatide) but are approved for different medical conditions-Zepbound for chronic weight management and Mounjaro for type 2 diabetes

ColonBroom GLP-1 Booster is a dietary supplement, not a prescription medication these are fundamentally different categories

Keywords: Atherosclerotic cardiovascular disease, Microvascular disease, Diabetes mellitus, Thrombosis, Chronic kidney disease, GLP-1R agonists Introduction Diabetes mellitus (DM) affects over 422 million individuals globally, with projections indicating a rise to 783 million by 2045, representing 10.5% of the adult population